Published in J Exp Med on April 01, 1994
Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J (1995) 2.84
A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity (2005) 1.81
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J Clin Invest (2007) 1.67
T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biol (2003) 1.49
Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49
Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med (2003) 1.43
An enhancer-blocking element between alpha and delta gene segments within the human T cell receptor alpha/delta locus. Proc Natl Acad Sci U S A (1997) 1.38
The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages. EMBO J (1998) 1.33
Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med (1994) 1.27
The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo. J Exp Med (2001) 1.27
Characterization of T cell differentiation in the murine gut. J Exp Med (2002) 1.14
Mechanisms controlling expression of the RAG locus during lymphocyte development. Curr Opin Immunol (2009) 1.13
Antigen-independent appearance of recombination activating gene (RAG)-positive bone marrow B cells in the spleens of immunized mice. J Exp Med (2000) 1.12
Regulation of pre-T cell receptor (pT alpha-TCR beta) gene expression during human thymic development. J Exp Med (1996) 1.09
Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development. Proc Natl Acad Sci U S A (2005) 1.04
Critical role for the common cytokine receptor gamma chain in intrathymic and peripheral T cell selection. J Exp Med (1996) 1.01
Proliferation kinetics associated with T cell receptor-beta chain selection of fetal murine thymocytes. J Exp Med (1996) 0.97
RAG2 is regulated differentially in B and T cells by elements 5' of the promoter. Proc Natl Acad Sci U S A (1999) 0.97
Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines. Mol Cell Biol (1999) 0.96
Regulation of T cell receptor delta gene rearrangement by c-Myb. J Exp Med (1996) 0.96
Developmental regulation of VDJ recombination by the core fragment of the T cell receptor alpha enhancer. J Exp Med (1997) 0.95
c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells. Mol Cell Biol (2000) 0.95
Identification of a late stage of small noncycling pTalpha- pre-T cells as immediate precursors of T cell receptor alpha/beta+ thymocytes. J Exp Med (1998) 0.92
T-cell receptor revision: friend or foe? Immunology (2010) 0.89
Extracellular signal-regulated kinase (ERK) activation by the pre-T cell receptor in developing thymocytes in vivo. J Exp Med (1999) 0.88
Beta-selection: abundance of TCRbeta-/gammadelta- CD44- CD25- (DN4) cells in the foetal thymus. Eur J Immunol (2007) 0.88
Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development. Semin Immunopathol (2008) 0.88
Regulation of T cell receptor delta gene rearrangement by CBF/PEBP2. J Exp Med (1997) 0.87
Development of thymic NK cells from double negative 1 thymocyte precursors. Blood (2011) 0.87
Efficient generation, purification, and expansion of CD34(+) hematopoietic progenitor cells from nonhuman primate-induced pluripotent stem cells. Blood (2012) 0.86
Identification of a committed T cell precursor population in adult human peripheral blood. J Exp Med (1997) 0.84
A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets. Immunity (2016) 0.83
Cross-lineage expression of Ig-beta (B29) in thymocytes: positive and negative gene regulation to establish T cell identity. Proc Natl Acad Sci U S A (1998) 0.83
Assessing a role for enhancer-blocking activity in gene regulation within the murine T-cell receptor alpha/delta locus. Immunology (2001) 0.82
Disorderly conduct in gammadelta versus alphabeta T cell lineage commitment. Semin Immunol (2010) 0.82
Bidirectional activity of the NWC promoter is responsible for RAG-2 transcription in non-lymphoid cells. PLoS One (2012) 0.81
Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens. PLoS One (2015) 0.78
Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood (2016) 0.77
Alternative splicing of rearranged T cell receptor delta sequences to the constant region of the alpha locus. Proc Natl Acad Sci U S A (1998) 0.77
The requirement for pre-TCR during thymic differentiation enforces a developmental pause that is essential for V-DJβ rearrangement. PLoS One (2011) 0.76
Illegitimate V(D)J recombination-mediated deletions in Notch1 and Bcl11b are not sufficient for extensive clonal expansion and show minimal age or sex bias in frequency or junctional processing. Mutat Res (2014) 0.76
Expression of Perforin Gene for Early Development of Nephrons in Olive Flounder (Paralichthys olivaceus). Balsaenggwa Saengsig (2013) 0.75
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50
The V(D)J recombination activating gene, RAG-1. Cell (1989) 9.79
RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science (1990) 9.33
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
Developmental biology of T cells in T cell-receptor transgenic mice. Annu Rev Immunol (1990) 5.27
A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol (1993) 4.44
V(D)J recombination: molecular biology and regulation. Annu Rev Immunol (1992) 3.59
Molecular and cellular events of T cell development. Adv Immunol (1989) 3.50
Exclusion and inclusion of alpha and beta T cell receptor alleles. Cell (1992) 3.34
Expression of T-cell antigen receptor genes during fetal development in the thymus. Nature (1985) 2.78
VDJ recombination. Immunol Today (1992) 2.74
Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking. Science (1991) 2.65
The development of functionally responsive T cells. Adv Immunol (1992) 2.03
A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 1.92
Lineage relationships and developmental kinetics of immature thymocytes: CD3, CD4, and CD8 acquisition in vivo and in vitro. J Exp Med (1990) 1.64
Engagement of the T-cell receptor during positive selection in the thymus down-regulates RAG-1 expression. Proc Natl Acad Sci U S A (1992) 1.43
Subpopulations of early thymocytes. A cross-correlation flow cytometric analysis of adult mouse Ly-2-L3T4-(CD8-CD4-) thymocytes using eight different surface markers. J Immunol (1988) 1.39
Post-transcriptional regulation of early T cell development by T cell receptor signals. Science (1992) 1.37
Different expression of the recombination activity gene RAG-1 in various populations of thymocytes, peripheral T cells and gut thymus-independent intraepithelial lymphocytes suggests two pathways of T cell receptor rearrangement. Eur J Immunol (1992) 1.24
The acquisition of CD4 and CD8 during the differentiation of early thymocytes in short-term culture. Int Immunol (1989) 1.14
Heterogeneity of immature (Lyt-2-/L3T4-) thymocytes. Identification of four major phenotypically distinct subsets differing in cell cycle status and in vitro activation requirements. J Immunol (1988) 1.06
Expression of T cell receptor genes in the thymus: localization of transcripts in situ and comparison of mature and immature subsets. Eur J Immunol (1990) 0.89
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol (1987) 5.07
Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (1985) 4.22
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol (2001) 3.89
An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature (1995) 3.78
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol (2000) 2.99
Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med (1984) 2.74
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
IL-4 rapidly produced by V beta 4 V alpha 8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity (1997) 2.54
Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-alpha/beta+ cells in the liver of mice. J Exp Med (1994) 2.53
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J (1993) 2.50
Selectively increased production of interferon-gamma by subsets of Lyt-2+ and L3T4+ T cells identified by expression of Pgp-1. J Immunol (1987) 2.39
Growth of mouse megakaryocyte colonies in vitro. Proc Natl Acad Sci U S A (1975) 2.38
Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J Exp Med (1987) 2.35
The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell (1997) 2.34
Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol (1998) 2.33
Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev (1980) 2.32
The beta-catenin--TCF-1 pathway ensures CD4(+)CD8(+) thymocyte survival. Nat Immunol (2001) 2.27
High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol (1985) 2.20
A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol (1987) 2.17
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell (1993) 2.11
Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity (1998) 2.03
Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med (2001) 2.02
Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol (1975) 1.94
Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature (1985) 1.90
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Deletion of self-reactive T cells before entry into the thymus medulla. Nature (1988) 1.88
Superantigens of mouse mammary tumor virus. Annu Rev Immunol (1995) 1.86
Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice. J Immunol (1999) 1.82
Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol (1979) 1.82
Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med (1995) 1.81
Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J Immunol (2000) 1.79
Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity. J Exp Med (1989) 1.78
Circulatory effects of heroin in patients with myocardial infarction. Lancet (1967) 1.75
Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proc Natl Acad Sci U S A (1988) 1.75
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
Yeast viral RNA polymerase is a transcriptase. Nucleic Acids Res (1980) 1.73
The cellular basis of T-cell memory. Annu Rev Immunol (1989) 1.70
Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J Exp Med (1993) 1.67
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med (1992) 1.64
Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med (1997) 1.64
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes (CTL): possible implications for the affinity of CTL antigen receptors. Immunol Rev (1982) 1.63
T cell antigen receptor expression in athymic (nu/nu) mice. Evidence for an oligoclonal beta chain repertoire. J Exp Med (1987) 1.61
Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors. J Immunol (1985) 1.61
Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev (1997) 1.60
Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip. Am J Cardiol (1966) 1.59
Structure and function of bacterial ribosomes. XII. Accumulation of 21 s particles by some cold-sensitive mutants of Escherichia coli. J Mol Biol (1971) 1.58
Natural killer cell receptors: the offs and ons of NK cell recognition. Cell (1995) 1.57
Phenotypic identification of memory cytolytic T lymphocytes in a subset of Lyt-2+ cells. J Immunol (1987) 1.56
Cytolytic T lymphocytes. Annu Rev Immunol (1983) 1.54
Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction. J Immunol (1985) 1.53
In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. Eur J Immunol (1995) 1.50
Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol (1986) 1.49
Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: analysis by flow microfluorometry. J Immunol (1981) 1.48
Clonal heterogeneity in the functional requirement for Lyt-2/3 molecules on cytolytic T lymphocytes: analysis by antibody blocking and selective trypsinization. J Exp Med (1982) 1.48
An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45
In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Eur J Immunol (1992) 1.45
Clonal analysis of cytolytic T lymphocyte specificity. I. Phenotypically distinct sets of clones as the cellular basis of cross-reactivity to alloantigens. J Exp Med (1980) 1.43
A role for gamma delta + T cells during experimental infection of mice with Leishmania major. J Immunol (1993) 1.42
Inhibition of T cell-mediated cytolysis by monoclonal antibodies directed against Lyt-2: heterogeneity of inhibition at the clonal level. J Immunol (1981) 1.42
Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med (1986) 1.40
Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Eur J Immunol (1989) 1.39
Functional analysis of T cell subsets from mice bearing the lpr gene. J Immunol (1985) 1.38
Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response. J Immunol (1995) 1.35
Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. J Immunol (1984) 1.33
T-cell activation. Annu Rev Cell Biol (1986) 1.31
Activated B cells express functional Fas ligand. Eur J Immunol (1996) 1.30
Secretion of IgG1 induction factor by T cell clones and hybridomas. Eur J Immunol (1985) 1.29
Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med (1993) 1.29
A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol (1991) 1.29
Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants. Eur J Immunol (1988) 1.29
Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci U S A (1990) 1.28
Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med (2000) 1.26
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur J Immunol (1999) 1.26
Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa. J Exp Med (1989) 1.26
Generation of cytotoxic T lymphocytes in vitro. IV. Functional activation of memory cells in the absence of DNA synthesis. J Exp Med (1975) 1.26
Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: segregation by velocity sedimentation. J Cell Physiol (1975) 1.25
Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med (1996) 1.25
Quantitation and clonal isolation of cytolytic T lymphocyte precursors selectively infiltrating murine sarcoma virus-induced tumors. J Exp Med (1981) 1.25
Production and characterization of monoclonal anti-Thy-1 antibodies that stimulate lymphokine production by cytolytic T cell clones. Eur J Immunol (1985) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Detection of perforin and granzyme A mRNA in infiltrating cells during infection of mice with lymphocytic choriomeningitis virus. Eur J Immunol (1989) 1.24
Functional correspondence between 30S ribosomal proteins of Escherichia coli and Bacillus stearothermophilus. Proc Natl Acad Sci U S A (1973) 1.24
Differential requirements for the induction of interleukin 2 responsiveness in L3T4+ and Lyt-2+ T cell subsets. J Exp Med (1985) 1.22
Abnormal distribution of T cell subsets in athymic mice. J Immunol (1986) 1.22
Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver. J Exp Med (1996) 1.22
Vacuolar H(+)-translocating pyrophosphatase is induced by anoxia or chilling in seedlings of rice. Plant Physiol (1995) 1.22
Cutting edge: apoptosis of superantigen-activated T cells occurs preferentially after a discrete number of cell divisions in vivo. J Immunol (1999) 1.22
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
Generation of cytotoxic T lymphocytes in vitro. III. Velocity sedimentation studies of the differentiation and fate of effector cells in long-term mixed leukocyte cultures. J Exp Med (1974) 1.21
Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med (1995) 1.21
Flow microfluorometric analysis of mouse thymus development in vivo and in vitro. Eur J Immunol (1983) 1.20